Soluble guanylate cyclase activator vericiguat prevents anthracycline-mediated cardiotoxicity and sarcopenia through NO-sGC-cGMP-NLRP3 pathway
13 May 2024 (10:12 - 10:21)
Organised by: 
About the speaker
National Cancer Institute G.Pascale Foundation IRCCS, Naples (Italy)
4 More presentations in this session
Doctor M. Ho (Hong Kong, HK)
Doctor M. Laufer-Perl (Tel Aviv, IL)
Doctor R. Lorca (Oviedo, ES)
Access the full session
The Event
Heart Failure 2024
13 May 2024
10:12 CET
You may be interested in
Congress Session
Congress Session
